Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Amortization of Deferred Charges: 2015-2025

Historic Amortization of Deferred Charges for Pediatrix Medical (MD) over the last 11 years, with Q3 2025 value amounting to $240000.0.

  • Pediatrix Medical's Amortization of Deferred Charges fell 874.52% to $240000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $928000.0, marking a year-over-year increase of 276.85%. This contributed to the annual value of $954000.0 for FY2024, which is 2300.24% down from last year.
  • Pediatrix Medical's Amortization of Deferred Charges amounted to $240000.0 in Q3 2025, which was down 874.52% from $228000.0 recorded in Q2 2025.
  • Pediatrix Medical's Amortization of Deferred Charges' 5-year high stood at $1.7 million during Q3 2021, with a 5-year trough of $200000.0 in Q1 2024.
  • In the last 5 years, Pediatrix Medical's Amortization of Deferred Charges had a median value of $282000.0 in 2023 and averaged $473210.5.
  • The largest annual percentage gain for Pediatrix Medical's Amortization of Deferred Charges in the last 5 years was 3028.66% (2021), contrasted with its biggest fall of 7359.9% (2021).
  • Over the past 5 years, Pediatrix Medical's Amortization of Deferred Charges (Quarter) stood at $815000.0 in 2021, then tumbled by 48.59% to $419000.0 in 2022, then crashed by 46.54% to $224000.0 in 2023, then rose by 12.05% to $251000.0 in 2024, then dropped by 4.38% to $240000.0 in 2025.
  • Its last three reported values are $240000.0 in Q3 2025, $228000.0 for Q2 2025, and $230000.0 during Q1 2025.